Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julia Furtner

Showing results (71-80 of 144) with videos related to

Pageof 15
Sort By:
Journal of Clinical Medicine|May 2, 2020
Sarcopenia in Neurological Patients: Standard Values for Temporal Muscle Thickness and Muscle Strength EvaluationAriane Steindl, Johannes Leitner, Matthias Schwarz, et al.
Neuro-Oncology|October 11, 2017
Visual and semiquantitative 11C-methionine PET: an independent prognostic factor for survival of newly diagnosed and treatment-naïve gliomasNina Poetsch, Adelheid Woehrer, Johanna Gesperger, et al.
Journal of Neurology|August 3, 2021
Prognostic factors in adult brainstem glioma: a tertiary care center analysis and review of the literatureAnnette Leibetseder, Johannes Leitner, Maximilian J Mair, et al.
Plos One|November 30, 2018
High correlation of temporal muscle thickness with lumbar skeletal muscle cross-sectional area in patients with brain metastasesJohannes Leitner, Sebastian Pelster, Veronika Schöpf, et al.
Frontiers in Oncology|February 23, 2023
Sex-specific radiomic features of L-[S-methyl-<sup>11</sup>C] methionine PET in patients with newly-diagnosed gliomas in relation to IDH1 predictabilityLaszlo Papp, Sazan Rasul, Clemens P Spielvogel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 7, 2025
[<sup>177</sup>Lu]Lu-DOTATATE for Recurrent Meningioma (LUMEN-1, EORTC-2334-BTG): Study Protocol for a Randomized Phase II TrialNathalie L Albert, Emeline Tabouret, Emilie Le Rhun, et al.
Neuroimage|February 18, 2019
High-resolution metabolic mapping of gliomas via patch-based super-resolution magnetic resonance spectroscopic imaging at 7TGilbert Hangel, Saurabh Jain, Elisabeth Springer, et al.
European Radiology|January 5, 2017
Survival prediction using temporal muscle thickness measurements on cranial magnetic resonance images in patients with newly diagnosed brain metastasesJulia Furtner, Anna S Berghoff, Omar M Albtoush, et al.
Journal of Clinical Medicine|March 11, 2023
Initial Evidence for Positive Effects of a Psychological Preparation Program for MRI "iMReady" in Children with Neurofibromatosis Type I and Brain Tumors-How to Meet the Patients' Needs BestLiesa Josephine Weiler-Wichtl, Jonathan Fries, Verena Fohn-Erhold, et al.
Investigative Radiology|March 11, 2015
Nephrogenic systemic fibrosis risk after liver magnetic resonance imaging with gadoxetate disodium in patients with moderate to severe renal impairment: results of a prospective, open-label, multicenter studyThomas Lauenstein, Francisco Ramirez-Garrido, Young Hoon Kim, et al.
Pageof 15

Showing results (71-80 of 144) with videos related to

Sort By:
Pageof 15
Journal of Clinical Medicine|May 2, 2020
Sarcopenia in Neurological Patients: Standard Values for Temporal Muscle Thickness and Muscle Strength EvaluationAriane Steindl, Johannes Leitner, Matthias Schwarz, et al.
Neuro-Oncology|October 11, 2017
Visual and semiquantitative 11C-methionine PET: an independent prognostic factor for survival of newly diagnosed and treatment-naïve gliomasNina Poetsch, Adelheid Woehrer, Johanna Gesperger, et al.
Journal of Neurology|August 3, 2021
Prognostic factors in adult brainstem glioma: a tertiary care center analysis and review of the literatureAnnette Leibetseder, Johannes Leitner, Maximilian J Mair, et al.
Plos One|November 30, 2018
High correlation of temporal muscle thickness with lumbar skeletal muscle cross-sectional area in patients with brain metastasesJohannes Leitner, Sebastian Pelster, Veronika Schöpf, et al.
Frontiers in Oncology|February 23, 2023
Sex-specific radiomic features of L-[S-methyl-<sup>11</sup>C] methionine PET in patients with newly-diagnosed gliomas in relation to IDH1 predictabilityLaszlo Papp, Sazan Rasul, Clemens P Spielvogel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 7, 2025
[<sup>177</sup>Lu]Lu-DOTATATE for Recurrent Meningioma (LUMEN-1, EORTC-2334-BTG): Study Protocol for a Randomized Phase II TrialNathalie L Albert, Emeline Tabouret, Emilie Le Rhun, et al.
Neuroimage|February 18, 2019
High-resolution metabolic mapping of gliomas via patch-based super-resolution magnetic resonance spectroscopic imaging at 7TGilbert Hangel, Saurabh Jain, Elisabeth Springer, et al.
European Radiology|January 5, 2017
Survival prediction using temporal muscle thickness measurements on cranial magnetic resonance images in patients with newly diagnosed brain metastasesJulia Furtner, Anna S Berghoff, Omar M Albtoush, et al.
Journal of Clinical Medicine|March 11, 2023
Initial Evidence for Positive Effects of a Psychological Preparation Program for MRI "iMReady" in Children with Neurofibromatosis Type I and Brain Tumors-How to Meet the Patients' Needs BestLiesa Josephine Weiler-Wichtl, Jonathan Fries, Verena Fohn-Erhold, et al.
Investigative Radiology|March 11, 2015
Nephrogenic systemic fibrosis risk after liver magnetic resonance imaging with gadoxetate disodium in patients with moderate to severe renal impairment: results of a prospective, open-label, multicenter studyThomas Lauenstein, Francisco Ramirez-Garrido, Young Hoon Kim, et al.
Pageof 15